Clinical Trials Directory

Trials / Completed

CompletedNCT06986044

EVALUATION OF SALIVA AND SERUM HEME OXYGENASE, ARYLESTERASE AND NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2 LEVELS IN PATIENTS WITH STAGE III PERIODONTITIS

Status
Completed
Phase
Study type
Observational
Enrollment
74 (actual)
Sponsor
Saglik Bilimleri Universitesi · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Periodontal disease is a chronic and progressive inflammatory disease in which the hard and soft tissues that support the teeth are damaged. It is caused by the interaction between harmful bacteria and the body's immune responses, and most periodontal tissues are damaged by the body's abnormal response to these microorganisms and their products. When bacteria enter the body, immune cells (neutrophils) produce reactive oxygen species (ROS) in a process called the "respiratory burst". These ROS damage cells, causing tissue destruction through a variety of mechanisms, including DNA damage, fat oxidation and protein damage. Studies have shown that neutrophils from individuals with periodontal disease produce more ROS than neutrophils from healthy individuals. High amounts of ROS lead to oxidative damage to gum tissue, periodontal ligament and alveolar bone. Oxidative stress occurs when antioxidants in the body are insufficient or when high levels of ROS are present. Therefore, disruption of the balance between oxidant and antioxidant activities is considered an important cause of oxidative damage in periodontal tissues. Parameters such as total antioxidant status (TAS), total oxidant status (TOS) and oxidative stress index (OSI) are used to determine oxidative stress. Furthermore, some enzymes such as arylesterase (ARE), heme oxygenase (HO) and nuclear factor erythroid 2-related factor 2 (NRF-2) are involved in defense mechanisms against oxidative stress. Many recent studies have shown a strong association between oxidative stress and periodontal disease.

Detailed description

This study was divided into 2 groups, 37 systemically and periodontally health individuals and 37 systemically healthy individuals with stage III grade B periodontitis were included. Clinical periodontal parameters plaque index (PI), gingival index (GI), probing pocket depth (SCD), bleeding on probing (BOP) and clinical attachment level (CAL) were recorded and saliva and serum samples were collected. ELISA method was used for analyses of TOS, TAS, OSI, ARE, HO-1, NRF-2 levels.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTSerum Total Oxidant StatusSerum total oxidant status
DIAGNOSTIC_TESTSalivary Total Oxidant StatusSalivary Total Oxidant Status
DIAGNOSTIC_TESTSerum Total Antioxidant StatusSerum Total Antioxidant Status
DIAGNOSTIC_TESTSalivary Total Antioxidant StatusSalivary Total Antioxidant Status
DIAGNOSTIC_TESTSerum Oxidative Stress IndexSerum Oxidative Stress Index
DIAGNOSTIC_TESTSalivary Oxidative Stress IndexSalivary Oxidative Stress Index
DIAGNOSTIC_TESTSerum ArylesteraseSerum Arylesterase
DIAGNOSTIC_TESTSalivary ArylesteraseSalivary Arylesterase
DIAGNOSTIC_TESTSerum Heme OxygenaseSerum Heme Oxygenase
DIAGNOSTIC_TESTSalivary Heme OxygenaseSalivary Heme Oxygenase
DIAGNOSTIC_TESTSerum Nuclear Factor Erythroid 2 Related Factor 2Serum Nuclear Factor Erythroid 2 Related Factor 2
DIAGNOSTIC_TESTSalivary Nuclear Factor Erythroid 2 Related Factor 2Salivary Nuclear Factor Erythroid 2 Related Factor 2
DIAGNOSTIC_TESTGingival IndexGingival Index
DIAGNOSTIC_TESTPlaque IndexPlaque Index
DIAGNOSTIC_TESTBleeding on Probing IndexBleeding on Probing Index
DIAGNOSTIC_TESTClinical Attachment LossClinical Attachment Loss
DIAGNOSTIC_TESTPocket DeepPocket Deep

Timeline

Start date
2023-05-01
Primary completion
2024-05-01
Completion
2024-09-15
First posted
2025-05-22
Last updated
2025-05-22

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06986044. Inclusion in this directory is not an endorsement.